Our study showed that WMW inhibited IL-1β production and relieved insulin resistance in palmitate-treated HepG2 cells via reduction of the expression of the three components of NLRP3 inflammasome: NLRP3, ASC, and caspase-1 (p20). The gene discussed is IL1B; the disease is Insulin resistance.